Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.75 HKD | +0.21% | +13.91% | -28.46% |
Business Summary
Number of employees: 435
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biologics of Oncology
100.0
%
| 194 | 100.0 % | 242 | 100.0 % | +24.60% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 194 | 100.0 % | 242 | 100.0 % | +24.60% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ting Xu
CEO | Chief Executive Officer | 51 | 08-10-31 |
Jing Han
CMP | Compliance Officer | 51 | 21-11-01 |
Jinbo Wang
CTO | Chief Tech/Sci/R&D Officer | 50 | 18-03-18 |
Liang Kong
CTO | Chief Tech/Sci/R&D Officer | 44 | 18-05-31 |
Lu Amy Sun
CTO | Chief Tech/Sci/R&D Officer | 67 | 19-05-31 |
Yang Liu
COO | Chief Operating Officer | 52 | 18-09-30 |
Jin Nan Wang
IRC | Investor Relations Contact | 42 | - |
Shaowei Yang
PRN | Corporate Officer/Principal | 48 | 17-06-12 |
Mike Liu
PRN | Corporate Officer/Principal | 58 | 18-04-30 |
Lok Yee Chan
SEC | Corporate Secretary | 35 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Cheng Wei
BRD | Director/Board Member | 56 | 19-11-23 |
Ting Xu
CEO | Chief Executive Officer | 51 | 08-10-31 |
Yang Liu
COO | Chief Operating Officer | 52 | 18-09-30 |
Dong Wu
BRD | Director/Board Member | 54 | 19-11-23 |
Zijian Guo
BRD | Director/Board Member | 63 | 21-08-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 964,843,807 | 474,790,857 ( 49.21 %) | 0 | 49.21 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.46% | 586M | |
+0.17% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B | |
-18.08% | 9.94B |
- Stock Market
- Equities
- 9966 Stock
- Company Alphamab Oncology